With the Russian invasion stalled and with a forceful counter-attack by Ukrainian armed forces, many observers caution that the Kremlin might be considering a show of force much as the U.S. did in the atomic bombings of Hiroshima and Nagasaki (The Cancer Letter, Feb. 25, March 4, March 11, 2022).
Steven A. Rosenberg will be presented with the Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research at the AACR Annual Meeting 2022, to be held in New Orleans April 8-13.
The American Association for Cancer Research has elected 33 scientists to its 2022 class of Fellows of the AACR Academy.
Krishna Komanduri was named division chief of hematology-oncology at University of California, San Francisco Health, effective July 1.
Charles Edward Geyer Jr. will join UPMC Hillman Cancer Center as co-director of its NCI National Clinical Trials Network efforts.
Courtney DeVries was named deputy director of WVU Cancer Institute.
Ashlee Harrison was named executive director of innovation and transformation of Huntsman Cancer Institute at the University of Utah.
Miruna Sasu was named president and CEO of COTA Inc. In her new role, she will lead efforts to drive broader adoption of real-world data by the life sciences industry to safely accelerate the speed of development and reduce the cost of cancer drugs.
The Association of Community Cancer Centers conferred its first class of Fellows of ACCC (FACCC) at its 48th Annual Meeting and Cancer Center Business Summit held in Washington, D.C., March 1-4.
AstraZeneca has launched the global R&D Postdoctoral Challenge to help accelerate the treatment of complex diseases, including cancer.
